Aptose Biosciences Inc (APTO): Thank you

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	63
Boards Moderated	0
Alias Born	01/30/2023

Wolverine3

Re: dcaf7 post# 335

Friday, 04/14/2023 6:46:46 PM

Friday, April 14, 2023 6:46:46 PM

Thank you

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent APTO News

Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 08:15:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:15:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 08:20:21 PM
Aptose Announces Results from Special Meeting of Shareholders • GlobeNewswire Inc. • 09/05/2024 08:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:35:07 PM
Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib • GlobeNewswire Inc. • 08/30/2024 08:30:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 08:35:12 PM
Aptose Announces Adjournment of its Special Meeting of Shareholders • GlobeNewswire Inc. • 08/15/2024 08:30:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 09:22:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 09:15:13 PM
Aptose Reports Results for the Second Quarter 2024 • GlobeNewswire Inc. • 08/08/2024 09:06:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:30:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 09:00:14 PM
Aptose Announces Receipt of Deficiency Notice from Nasdaq • GlobeNewswire Inc. • 07/19/2024 09:00:00 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/17/2024 03:43:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 11:40:15 AM
Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:35:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 02:32:05 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/03/2024 10:05:42 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 12:05:15 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/15/2024 03:47:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 09:06:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:15:19 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 03:35:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:45:13 PM

More APTO News

InvestorsHub NewsWire

FEATURED CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • Oct 8, 2024 8:00 AM

BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM

Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM

North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM

Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM

Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover